Whole exome sequencing identification of novel candidate genes in patients with proliferative diabetic retinopathy

Vision Research

Volumn 139, Issue , 2017, Pages 168-176

  Ung, Cindy ^a   Sanchez, Angie V ^b   Shen, Lishuang ^c   Davoudi, Samaneh ^a   Ahmadi, Tina ^a   Navarro Gomez, Daniel ^a   Chen, Ching J ^d   Hancock, Heather ^d   Penman, Alan ^d   Hoadley, Suzanne ^d   Consugar, Mark ^a   Restrepo, Carlos ^e   Shah, Vinay A ^f   Arboleda Velasquez, Joseph F ^b   Sobrin, Lucia ^a   Gai, Xiaowu ^c   Kim, Leo A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^e UNIVERSIDAD CES   (Colombia)

^f UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Aberrant angiogenesis; Candidate genes; Diabetic retinopathy; Whole exome sequencing

Indexed keywords

ADULT; APOB GENE; ARTICLE; CELL CULTURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DNA SPLICING; ENDOTHELIUM CELL; ETHNICITY; FAM132A GENE; FEMALE; FRAMESHIFT MUTATION; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAT1 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONSENSE MUTATION; NULL ALLELE; PATHOGENESIS; PHENOTYPE; PHF21A GENE; PKHD1L1 GENE; PRIORITY JOURNAL; PROLIFERATIVE DIABETIC RETINOPATHY; RETINA CELL; RNA SPLICE SITE; SLC5A9 GENE; TMEM217 GENE; VALIDATION PROCESS; VEGFB GENE; VPS13B GENE; WHOLE EXOME SEQUENCING; ZNF600 GENE; DIABETIC RETINOPATHY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; RETINA NEOVASCULARIZATION;

DIABETIC RETINOPATHY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RETINAL NEOVASCULARIZATION; WHOLE EXOME SEQUENCING;

EID: 85019046056     PISSN: 00426989     EISSN: 18785646     Source Type: Journal    
DOI: 10.1016/j.visres.2017.03.007     Document Type: Article

References (54)

1. Abhary, S., Burdon, K.P., Gupta, A., Lake, S., Selva, D., Petrovsky, N., et al. Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy. Investigative Ophthalmology & Visual Science 50:12 (2009), 5552–5558.
2. Abhary, S., Hewitt, A.W., Burdon, K.P., Craig, J.E., A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes 58:9 (2009), 2137–2147.
3. Aiello, L.P., Angiogenic pathways in diabetic retinopathy. New England Journal of Medicine 353:8 (2005), 839–841.
4. Awata, T., Inoue, K., Kurihara, S., Ohkubo, T., Watanabe, M., Inukai, K., et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51:5 (2002), 1635–1639.
5. Awata, T., Yamashita, H., Kurihara, S., Morita-Ohkubo, T., Miyashita, Y., Katayama, S., et al. A genome-wide association study for diabetic retinopathy in a Japanese population: potential association with a long intergenic non-coding RNA. PLoS One, 9(11), 2014, e111715.
6. Brakenhielm, E., Veitonmaki, N., Cao, R., Kihara, S., Matsuzawa, Y., Zhivotovsky, B., et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proceedings of the National Academy of Sciences of the United States of America 101:8 (2004), 2476–2481.
7. Brugger, B., Erben, G., Sandhoff, R., Wieland, F.T., Lehmann, W.D., Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proceedings of the National Academy of Sciences of the United States of America 94:6 (1997), 2339–2344.
8. Bujakowska, K.M., Consugar, M., Place, E., Harper, S., Lena, J., Taub, D.G., et al. Targeted exon sequencing in Usher syndrome type I. Investigative Ophthalmology & Visual Science 55:12 (2014), 8488–8496.
9. Burdon, K.P., Fogarty, R.D., Shen, W., Abhary, S., Kaidonis, G., Appukuttan, B., et al. Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 gene. Diabetologia 58:10 (2015), 2288–2297.
10. Chen, P., Ong, R.T., Tay, W.T., Sim, X., Ali, M., Xu, H., et al. A study assessing the association of glycated hemoglobin A1C (HbA1C) associated variants with HbA1C, chronic kidney disease and diabetic retinopathy in populations of Asian ancestry. PLoS One, 8(11), 2013, e79767.
11. Cheung, C.Y., Hui, E.Y., Lee, C.H., Kwok, K.H., Gangwani, R.A., Li, K.K., et al. Impact of genetic loci identified in genome-wide association studies on diabetic retinopathy in chinese patients with type 2 diabetes. Investigative Ophthalmology & Visual Science 57:13 (2016), 5518–5524.
12. Davoudi, S., Papavasileiou, E., Roohipoor, R., Cho, H., Kudrimoti, S., Hancock, H., et al. Optical coherence tomography characteristics of macular edema and hard exudates and their association with lipid serum levels in type 2 diabetes. Retina 36:9 (2016), 1622–1629.
13. Demirkan, A., van Duijn, C.M., Ugocsai, P., Isaacs, A., Pramstaller, P.P., Liebisch, G., et al. Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations. PLoS Genetics, 8(2), 2012, e1002490.
14. Emond, M.J., Louie, T., Emerson, J., Chong, J.X., Mathias, R.A., Knowles, M.R., et al. Exome sequencing of phenotypic extremes identifies CAV2 and TMC6 as interacting modifiers of chronic pseudomonas aeruginosa infection in cystic fibrosis. PLoS Genetics, 11(6), 2015, e1005273.
15. Emond, M.J., Louie, T., Emerson, J., Zhao, W., Mathias, R.A., Knowles, M.R., et al. Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Nature Genetics 44:8 (2012), 886–889.
16. Enomoto, T., Ohashi, K., Shibata, R., Higuchi, A., Maruyama, S., Izumiya, Y., et al. Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose metabolism. Journal of Biological Chemistry 286:40 (2011), 34552–34558.
17. Feenstra, D.J., Yego, E.C., Mohr, S., Modes of retinal cell death in diabetic retinopathy. Journal of Clinical & Experimental Ophthalmology, 4(5), 2013, 298.
18. Fu, L.L., Lin, Y., Yang, Z.L., Yin, Y.B., Association analysis of genetic polymorphisms of TCF7L2, CDKAL1, SLC30A8, HHEX genes and microvascular complications of type 2 diabetes mellitus. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 29:2 (2012), 194–199.
19. Fu, Y.P., Hallman, D.M., Gonzalez, V.H., Klein, B.E., Klein, R., Hayes, M.G., et al. Identification of diabetic retinopathy genes through a genome-wide association study among Mexican-Americans from Starr County, Texas. Journal of Ophthalmology, 2010.
20. Grading diabetic retinopathy from stereoscopic color fundus photographs–an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group, Ophthalmology 98:5 Suppl (1991), 786–806.
21. Grassi, M.A., Tikhomirov, A., Ramalingam, S., Below, J.E., Cox, N.J., Nicolae, D.L., Genome-wide meta-analysis for severe diabetic retinopathy. Human Molecular Genetics 20:12 (2011), 2472–2481.
22. Grassi, M.A., Tikhomirov, A., Ramalingam, S., Lee, K.E., Hosseini, S.M., Klein, B.E., et al. Replication analysis for severe diabetic retinopathy. Investigative Ophthalmology & Visual Science 53:4 (2012), 2377–2381.
23. Hagberg, C.E., Mehlem, A., Falkevall, A., Muhl, L., Fam, B.C., Ortsater, H., et al. Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes. Nature 490:7420 (2012), 426–430.
24. Hietala, K., Forsblom, C., Summanen, P., Groop, P.H., FinnDiane Study, G. Heritability of proliferative diabetic retinopathy. Diabetes 57:8 (2008), 2176–2180.
25. Hosseini, S.M., Boright, A.P., Sun, L., Canty, A.J., Bull, S.B., Klein, B.E., et al. The association of previously reported polymorphisms for microvascular complications in a meta-analysis of diabetic retinopathy. Human Genetics 134:2 (2015), 247–257.
26. Huang, Y.C., Lin, J.M., Lin, H.J., Chen, C.C., Chen, S.Y., Tsai, C.H., et al. Genome-wide association study of diabetic retinopathy in a Taiwanese population. Ophthalmology 118:4 (2011), 642–648.
27. Kirchhoff, K., Machicao, F., Haupt, A., Schafer, S.A., Tschritter, O., Staiger, H., et al. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 51:4 (2008), 597–601.
28. Klein, R., Klein, B.E., Moss, S.E., Cruickshanks, K.J., The wisconsin epidemiologic study of diabetic retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105:10 (1998), 1801–1815.
29. Lachin, J.M., Genuth, S., Nathan, D.M., Zinman, B., Rutledge, B.N., Group, D. E. R. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial–revisited. Diabetes 57:4 (2008), 995–1001.
30. Liew, G., Klein, R., Wong, T.Y., The role of genetics in susceptibility to diabetic retinopathy. International Ophthalmology Clinics 49:2 (2009), 35–52.
31. Lin, H.J., Huang, Y.C., Lin, J.M., Wu, J.Y., Chen, L.A., Tsai, F.J., Association of genes on chromosome 6, GRIK2, TMEM217 and TMEM63B (linked to MRPL14) with diabetic retinopathy. Ophthalmologica 229:1 (2013), 54–60.
32. Marcovina, S., Packard, C.J., Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. Journal of Internal Medicine 259:5 (2006), 437–446.
33. Matsumoto, T., Kobayashi, T., Kamata, K., Role of lysophosphatidylcholine (LPC) in atherosclerosis. Current Medicinal Chemistry 14:30 (2007), 3209–3220.
34. McQueen, M.J., Hawken, S., Wang, X., Ounpuu, S., Sniderman, A., Probstfield, J., et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 372:9634 (2008), 224–233.
35. Miao, Y., Cui, L., Chen, Z., Zhang, L., Gene expression profiling of DMU-212-induced apoptosis and anti-angiogenesis in vascular endothelial cells. Pharmaceutical Biology 54:4 (2016), 660–666.
36. Ng, D.P., Human genetics of diabetic retinopathy: current perspectives. Journal of Ophthalmology, 2010.
37. Ng, Z.X., Kuppusamy, U.R., Tajunisah, I., Fong, K.C., Chua, K.H., Investigation of SLC2A1 26177A/G gene polymorphism via high resolution melting curve analysis in Malaysian patients with diabetic retinopathy. Journal of Diabetes and Its Complications 26:5 (2012), 388–392.
38. Papavasileiou, E., Davoudi, S., Roohipoor, R., Cho, H., Kudrimoti, S., Hancock, H., et al. Association of serum lipid levels with retinal hard exudate area in African Americans with type 2 diabetes. Graefes Archive for Clinical and Experimental Ophthalmology, 2016.
39. Peng, D., Wang, J., Zhang, R., Jiang, F., Tang, S., Chen, M., et al. Common variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetologia 58:6 (2015), 1231–1238.
40. Penman, A., Hancock, H., Papavasileiou, E., James, M., Idowu, O., Riche, D.M., et al. Risk factors for proliferative diabetic retinopathy in african americans with type 2 diabetes. Ophthalmic Epidemiology 23:2 (2016), 88–93.
41. Ruta, L.M., Magliano, D.J., Lemesurier, R., Taylor, H.R., Zimmet, P.Z., Shaw, J.E., Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries. Diabetic Medicine 30:4 (2013), 387–398.
42. Sheu, W.H., Kuo, J.Z., Lee, I.T., Hung, Y.J., Lee, W.J., Tsai, H.Y., et al. Genome-wide association study in a Chinese population with diabetic retinopathy. Human Molecular Genetics 22:15 (2013), 3165–3173.
43. Shtir, C., Aldahmesh, M.A., Al-Dahmash, S., Abboud, E., Alkuraya, H., Abouammoh, M.A., et al. Exome-based case-control association study using extreme phenotype design reveals novel candidates with protective effect in diabetic retinopathy. Human Genetics 135:2 (2016), 193–200.
44. Siepel, A., Bejerano, G., Pedersen, J.S., Hinrichs, A.S., Hou, M., Rosenbloom, K., et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Research 15:8 (2005), 1034–1050.
45. Sun, C.Y., Lee, C.C., Hsieh, M.F., Chen, C.H., Chou, K.M., Clinical association of circulating VEGF-B levels with hyperlipidemia and target organ damage in type 2 diabetic patients. Journal of Biological Regulators and Homeostatic Agents 28:2 (2014), 225–236.
46. Takagi, H., King, G.L., Aiello, L.P., Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes 47:9 (1998), 1480–1488.
47. Tan, B.K., Lewandowski, K.C., O'Hare, J.P., Randeva, H.S., Insulin regulates the novel adipokine adipolin/CTRP12: in vivo and ex vivo effects. Journal of Endocrinology 221:1 (2014), 111–119.
48. Tazawa, S., Yamato, T., Fujikura, H., Hiratochi, M., Itoh, F., Tomae, M., et al. SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose. Life Sciences 76:9 (2005), 1039–1050.
49. Wang, L., Folsom, A.R., Zheng, Z.J., Pankow, J.S., Eckfeldt, J.H., Investigators, A.S., Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Clinical Nutrition 78:1 (2003), 91–98.
50. Wu, M., Chen, Y., Wilson, K., Chirindel, A., Ihnat, M.A., Yu, Y., et al. Intraretinal leakage and oxidation of LDL in diabetic retinopathy. Investigative Ophthalmology & Visual Science 49:6 (2008), 2679–2685.
51. Yu, J.Y., Lyons, T.J., Modified lipoproteins in diabetic retinopathy: a local action in the retina. Journal of Clinical & Experimental Ophthalmology, 4(6), 2013.
52. Yuen, R.K., Thiruvahindrapuram, B., Merico, D., Walker, S., Tammimies, K., Hoang, N., et al. Whole-genome sequencing of quartet families with autism spectrum disorder. Nature Medicine 21:2 (2015), 185–191.
53. Zhang, X., Saaddine, J.B., Chou, C.F., Cotch, M.F., Cheng, Y.J., Geiss, L.S., et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 304:6 (2010), 649–656.
54. Zhao, T., Zhao, J., Association between the -634C/G polymorphisms of the vascular endothelial growth factor and retinopathy in type 2 diabetes: a meta-analysis. Diabetes Research and Clinical Practice 90:1 (2010), 45–53.